February 9, 2011

HELIX BIOPHARMA CORP. TO PRESENT AT THE THIRD INTERNATIONAL CONFERENCE ON DRUG DISCOVERY AND THERAPY IN DUBAI ON FEBRUARY 10 (PDF)

AURORA, Ontario, February 9, 2011 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a developer of
biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Heman Chao, Ph.D.,
Chief Scientific Officer, will be presenting at the Third International Conference on Drug Discovery and Therapy on February 10, 2011 at the Dubai Women’s College in Dubai, UAE.